TXG
10X Genomics Inc
93.50$
+5.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.7% | -23.4% | +8.6% | -0.9% | +8.8% | -6.1% | +11.6% | -13.8% | +11.4% | -9.1% | +0.1% | – | |
| – | +17.3% | -29.5% | +1.6% | -7.4% | +19.5% | -8.6% | -3.3% | +1.8% | +8.8% | -15.7% | -13.7% | – | |
| – | +21.2% | -19.8% | +12.2% | +2.1% | +4.3% | -5.0% | +18.6% | -19.8% | +12.7% | -6.1% | +6.0% | – | |
| – | -39.5% | +5.2% | -8.3% | +5.2% | +1.2% | -4.1% | -4.7% | -6.6% | -2.1% | +1.6% | -0.1% | – | |
| – | +0.5% | +3.6% | -3.2% | -1.6% | +10.1% | -0.2% | -17.0% | +1.2% | +1.7% | -13.4% | +18.5% | – | |
| – | -10.2% | -9.7% | -5.5% | +1.3% | +8.7% | -10.0% | -34.4% | +39.6% | +0.0% | -7.1% | +7.2% | – | |
| – | – | – | – | – | – | – | – | -207.0% | – | – | – | – | |
| – | +700.0% | -87.5% | +0.0% | +100.0% | +300.0% | -100.0% | – | +0.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -176.2% | – | – | – | – | |
| – | +89.5% | -8.8% | -61.9% | +60.8% | -50.7% | +31.5% | +188.6% | -129.8% | – | -41.2% | -214.6% | – | |
| – | – | – | – | – | – | – | – | -179.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -134.2% | – | -101.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.